worldwide lot focus remdesivir potentially best shot says virologist stephen griffin university leeds uk fast flowing conflicting information remdesivir left people reeling past weeks rush find therapies combat covid-19 small clinical trials control groups common annoyed non controlled studies says geoffrey porges analyst investment bank svb leerink new york city reassuring 50-60 patients discharged hospital disease gets better uncertainty remdesivir watchers waiting anxiously final results niaid trial not expected end May lieu vaccine year away effective therapies critical reducing deaths limiting economic damage pandemic despite flood small clinical trials therapy convincingly shown boost survival people covid-19 niaid results new sheen